Pharyngal(Pharyngal) - _专利_临床

概要

基本信息

药物类型

小分子化药

别名-

靶点-

作用机制-

治疗领域

感染口颌疾病耳鼻咽喉疾病+ [1]

在研适应症-

非在研适应症

咽炎

原研机构

Bosnalijek dd

在研机构-

非在研机构

Bosnalijek d.d.

最高研发阶段无进展临床3期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

1

项与 Pharyngal 相关的临床试验

NCT03282045 / Completed临床3期

A Multicenter, Single-blind, Randomized, Placebo-controlled Comparative Study on Efficacy and Safety of the Lysobact Complete Spray®, Tantum Verde® Spray and Pharyngal® Oromucosal Spray in the Treatment of Acute Sore Throat in Common Cold

The primary objective of this multicenter, single-blind, randomized, placebo-controlled, prospective, comparative study with parallel design and 4-arms is to evaluate superiority of Lysobact Complete Spray® against placebo and non inferiority of Lysobact Complete Spray® against active comparators (Tantum Verde® and Pharyngal®) in terms of efficacy based on the pain VAS scores evaluated by the patient using Sore Throat Pain Intensity Scale (STPIS).

开始日期2016-10-01

申办/合作机构

Bosnalijek d.d.

[+1]

100 项与 Pharyngal 相关的临床结果

登录后查看更多信息

100 项与 Pharyngal 相关的转化医学

登录后查看更多信息

100 项与 Pharyngal 相关的专利（医药）

登录后查看更多信息

100 项与 Pharyngal 相关的药物交易

登录后查看更多信息